TYLER, Texas– NanoVibronix, Inc. (NASDAQ: NAOV) announced that its ENvue Medical division has signed an agreement with a regional acute care hospital in upstate New York to implement two ENvue™ Navigation Systems for bedside placement of nasoenteric feeding tubes. The systems are expected to be delivered in the third quarter of 2025 and mark ENvue’s first system adoption in the northeastern U.S.
The ENvue system uses electromagnetic navigation technology to provide real-time visualization of feeding tube placement, enabling clinicians to guide tubes with greater accuracy and safety directly at the bedside. The technology is designed to improve workflow, reduce reliance on confirmatory imaging, and support broader institutional protocols for enteral access.
“Increasingly, hospitals are taking a more strategic approach to investing in enteral access technology,” said Dr. Doron Besser, CEO of NanoVibronix and ENvue Medical. “We are seeing a clear shift away from legacy tools toward more advanced solutions that emphasize safety, workflow integration, and long-term value.”
The agreement represents a dual-system acquisition and is part of a broader hospital initiative to modernize feeding tube placement protocols. It also reflects growing interest in point-of-care solutions that align with institutional efficiency and patient safety goals.
The ENvue Navigation System, already FDA-cleared for adult use, is currently deployed in intensive care, step-down, and medical-surgical units across the country. The new deal builds on recent commercial momentum in the southeastern United States and is a key milestone in ENvue’s national expansion strategy.
The announcement comes shortly after ENvue received a U.S. patent for its electromagnetic navigation system for pediatric feeding applications, further advancing the company’s product development roadmap.
Dr. Besser noted that additional agreements are in the pipeline and that new innovations leveraging emerging technologies are expected to expand ENvue’s market presence. “We’re energized by the opportunities ahead and remain focused on delivering solutions that meet the evolving clinical needs of hospitals and healthcare providers.”
